Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.74 |
| ▸ | CES1 | P23141 | 2/20 | 0.74 |
| ▸ | DAO | P14920 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1066873 | 0.85 | CES2 (1.00) | CES2CES1DAOKMT2ANPC1 | |
| SCHEMBL9148741 | 0.81 | CES2 (0.81) | CES2CES1DAOKMT2ANPC1 | |
| SCHEMBL120212 | 0.81 | — | — | |
| SCHEMBL937615 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL485645 | 0.79 | — | — | |
| SCHEMBL71555 | 0.79 | CES2 (0.77) | CES2CES1DAOKMT2ANPC1 | |
| Urea SCHEMBL4239865 | 0.79 | CES2 (0.62) | CES2CES1DAOKMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL3194035 | 0.79 | CES2 (0.62) | CES2CES1DAOKMT2ANPC1 | |
| SCHEMBL1379741 | 0.78 | CES2 (0.56) | CES2CES1DAOKMT2ANPC1 | |
| SCHEMBL1883541 | 0.77 | CES2 (0.74) | CES2CES1DAOKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2764034-B1 | POLYMERS BASED ON BENZODIONES | CLAP CO LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| CN-114502543-A | Targeted protein compounds, pharmaceutical compositions and therapeutic applications thereof | 拜欧斯瑞克斯公司 | 2022-05-13 | — | — | CN | disclosed |
| EP-3019196-B1 | COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-06-06 | — | — | EP | disclosed |
| US-9240551-B2 | Polymers based on benzodiones | BASF SE (DE) | 2016-01-19 | — | — | US | disclosed |
| US-9240551-B2 | Polymers based on benzodiones | BASF SE (DE) | 2016-01-19 | — | — | US | disclosed |
| US-20140302637-A1 | POLYMERS BASED ON BENZODIONES | BASF SE (DE) | 2014-10-09 | — | — | US | disclosed |
| US-20140302637-A1 | POLYMERS BASED ON BENZODIONES | BASF SE (DE) | 2014-10-09 | — | — | US | disclosed |
| WO-2013050401-A2 | POLYMERS BASED ON BENZODIONES | BASF SE (DE) | 2013-04-11 | — | — | WO | disclosed |
| EP-1636217-B1 | 2-IMIDAZO-BENZOTHIAZOLES AS ADENOSINE RECEPTOR LIGANDS | HOFFMANN LA ROCHE (CH) | 2008-09-03 | — | — | EP | disclosed |
| EP-1450796-B1 | BENZOTHIAZOLE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2008-04-09 | — | — | EP | disclosed |
| US-20030069294-A1 | Alpha-substituted carboxylic acid derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| WO-2002050091-A1 | MACROLIDE ANTIBIOTICS | GLAXO GROUP LIMITED (GB) | 2002-06-27 | — | — | WO | disclosed |
| EP-1167357-A1 | ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-0387677-B1 | Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation | CASSELLA FARBWERKE MAINKUR AG (DE) | 1994-03-16 | — | — | EP | disclosed |
| EP-0388750-B1 | Thienyl piperazines, process for their preparation, their use, pharmaceutical agents containing them and their production | CASSELLA FARBWERKE MAINKUR AG (DE) | 1994-01-26 | — | — | EP | disclosed |
| US-5015659-A | Cognition activators to slow aging of the brain | CASSELLA AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | disclosed |
| US-4987134-A | DISORDERS OF BRAIN FUNCTIONS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1991-01-22 | — | — | US | disclosed |
| EP-0388750-A1 | Thienyl piperazines, process for their preparation, their use, pharmaceutical agents containing them and their production | CASSELLA Aktiengesellschaft (DE) | 1990-09-26 | — | — | EP | disclosed |
| EP-0387677-A2 | Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation | CASSELLA Aktiengesellschaft (DE) | 1990-09-19 | — | — | EP | disclosed |
| US-4118298-A | PHOTOINITIATOR | STAUFFER CHEMICAL COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069294-A1 | Alpha-substituted carboxylic acid derivatives | SLC5A1, SLC2A1, GPR119 | CES2 718/4885CES1 33/4885DAO 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.